Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Clinical and Experimental Rheumatology
|
November 24, 2004
Cost-effectiveness of anti-tumor necrosis factor agents
J B Wong
Acta Gastro-Enterologica Belgica
|
July 11, 1998
Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness
J B Wong
The American Journal of Medicine
|
February 1, 2000
Cost-effectiveness of treatments for chronic hepatitis C
J B Wong
Acta Gastro-Enterologica Belgica
|
August 13, 2002
Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
J B Wong, F Nevens
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 1, 1993
Commentary: fine-tuning life-expectancy calculations using Markov processes
F A Sonnenberg, J B Wong
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
January 1, 1994
Meta-analysis of failure-time data with adjustment for covariates
M G Hunink, J B Wong
Annals of Internal Medicine
|
November 14, 2000
Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis
J B Wong, R S Koff
The New England Journal of Medicine
|
August 14, 1997
Postexposure treatment of HIV
R W Li, J B Wong
The American Journal of Gastroenterology
|
August 13, 1999
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk
D Provenzale, C Schmitt, J B Wong
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?
M F Drummond, M Barbieri, J B Wong
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Clinical and Experimental Rheumatology
|
November 24, 2004
Cost-effectiveness of anti-tumor necrosis factor agents
J B Wong
Acta Gastro-Enterologica Belgica
|
July 11, 1998
Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness
J B Wong
The American Journal of Medicine
|
February 1, 2000
Cost-effectiveness of treatments for chronic hepatitis C
J B Wong
Acta Gastro-Enterologica Belgica
|
August 13, 2002
Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
J B Wong, F Nevens
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 1, 1993
Commentary: fine-tuning life-expectancy calculations using Markov processes
F A Sonnenberg, J B Wong
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
January 1, 1994
Meta-analysis of failure-time data with adjustment for covariates
M G Hunink, J B Wong
Annals of Internal Medicine
|
November 14, 2000
Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis
J B Wong, R S Koff
The New England Journal of Medicine
|
August 14, 1997
Postexposure treatment of HIV
R W Li, J B Wong
The American Journal of Gastroenterology
|
August 13, 1999
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk
D Provenzale, C Schmitt, J B Wong
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?
M F Drummond, M Barbieri, J B Wong
Page
of 8